Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide vs Standard Triple Therapy for H. pylori in Children
NCT07086937Completed
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of nitazoxanide in Helicobacter pylori infection (2 arms). Primary endpoint: Treatment efficacy at 6 weeks. Started Jan 2025; status: completed.
02
Drugs
nitazoxanide
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07086937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07086937.